Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,158,079
-$961,820 QoQ
Shares Held
48,093
-36.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,240
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chicago Capital, LLC holds $139,654,335 across 9 Drug Manufacturers - General names. PFE ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
87,354 | $104,775,016 | |
| 2 | JNJ |
Johnson & Johnson
|
56,172 | $14,266,002 | |
| 3 | ABBV |
AbbVie Inc.
|
40,087 | $10,087,492 | |
| 4 | AMGN |
Amgen Inc
|
11,787 | $4,268,308 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,111 | $3,483,763 | |
| 6 | PFE |
Pfizer Inc
This page
|
48,093 | $1,158,079 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,250 | $648,225 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,332 | $547,304 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,158,079 | 48,093 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,119,899 | 75,495 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,779,338 | 111,620 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,812,813 | 110,393 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,619,762 | 108,076 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,467,482 | 97,375 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,861,583 | 70,169 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,196,401 | 75,895 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,104,012 | 75,197 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,015,260 | 72,622 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,179,575 | 75,706 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,697,152 | 81,313 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,997,086 | 81,709 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,329,443 | 81,604 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,171,243 | 81,406 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,578,080 | 81,766 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $4,283,845 | 81,706 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $4,075,645 | 78,726 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $4,575,548 | 77,486 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,325,447 | 77,318 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,996,836 | 76,528 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,768,986 | 76,428 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $2,782,946 | 75,603 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $2,671,757 | 72,800 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,508,092 | 76,700 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,395,772 | 73,400 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||